Monarch Bioimplants
Monarch Bioimplants: Investment supports development of promising biosynthetic nerve repair technology, NeuroShieldTM Monarch Bioimplants, a biomedical implant development firm responsible for creating a revolutionary chitosan membrane for peripheral nerve repair, today announced a three-year, €20 million (approximately USD $23 million) share subscription and drawdown agreement with GEM Global Yield LLC SCS, part of the Global…